NanoCarrier is a small nanotechnology company focused on the development of drug delivery for cancer treatments, and last year listed on the Tokyo Stock Exchange’s Mothers market for start-ups.
The company, based in Tokyo, was set up in 1996 by two Japanese professors, Kazunori Kataoka of University of Tokyo and Professor Teruo Okano of Tokyo Women’s Medical University, who developed the technology for which one product is in phase II of its clinical trials.
